Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Deval L. Patrick currently holds 19,055 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deval L. Patrick has been a net seller of GBT stock. They have purchased $314.7K and sold $5.2M worth of shares.
Deval L. Patrick's most recent insider trade was on Sep 15, 2026, when they sold 337 shares at $0.00 per share.
Deval L. Patrick serves as Executive at Global Blood Therapeutics, Inc. (GBT). They have executed 59 insider transactions totaling $5.5M over their tenure at the company.
Deval L. Patrick holds the position of Executive at Global Blood Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Deval L. Patrick has shown a selling trading pattern, with $314.7K in total purchases and $5.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Deval L. Patrick was on Sep 12, 2022, when they sold $1.5M worth of CERE shares. This transaction involved 47,705 shares at $30.78 per share.
Deval L. Patrick currently owns 19,055 shares of Global Blood Therapeutics, Inc. (GBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Deval L. Patrick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Deval L. Patrick has 59 Form 4 filings on record as an insider at Global Blood Therapeutics, Inc..
Set alerts for Deval L. Patrick and 40,000+ other insiders.